相关实验视频
Updated: Jun 7, 2025

06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
429
支持痴呆症管理的辅助技术:审查范围审查的协议
Chaitali Desai1,2, Erica Dove1,2, Jarshini Nanthakumar3
1Rehabilitation Sciences Institute, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
JMIR research protocols
|November 11, 2024
概括
本范围审查综合了在家中治疗痴呆症的辅助技术 (AT) 的证据. 它旨在确定研究缺口,并为个人和政策制定者提供决策信息.
科学领域:
- 老年学是一门学科.
- 康复科学 康复科学 康复科学
- 医疗信息学 医疗信息学
背景情况:
- 超过60%的患有痴呆症的加拿大人生活在家中,其中25%的人依靠护理伙伴提供日常帮助.
- 辅助技术 (AT) 对于保持痴呆症患者在家庭和社区环境中的健康,安全和独立至关重要.
- 越来越多的关于治疗痴呆症管理的AT文献需要有效的综合来实现实际应用.
研究的目的:
- 进行关于痴呆症管理辅助技术 (AT) 发表文献的范围审查.
- 综合审查层面的证据,支持痴呆症患者及其在家庭和社区环境中的护理伙伴.
- 确定有关AT使用和可访问性的知识差距和未来研究领域.
主要方法:
- 该审查遵循乔安娜·布里格斯研究所 (JBI) 的范围审查框架和PRISMA-ScR指南.
- 将搜索六个电子数据库,使用人口-概念-上下文 (PCC) 框架选文章.
- 数据提取将集中在文章细节,AT特征,设置/人口特点和关键审查结果上.
主要成果:
- 在6个电子数据库中,共发现了10978个独特的引用.
- 该审查目前处于全文选阶段,预计将于2024年10月完成.
- 初步结果表明,关于AT用于痴呆症管理的大量研究.
结论:
- 这一综述将提供关于AT用于痴呆症管理的科学文献的全面概述.
- 预计研究结果将提供基于证据的见解,了解AT类型,使用,可用性和访问挑战.
- 该综合旨在为政策和实践提供信息,最终改善患有痴呆症的个体的福祉.
相关概念视频
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Documentation in Long-Term and Home Healthcare Setting
873
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
873
Dementia
97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
97

